Rocky Mountain Cancer Centers, LLP is a clinical research site located in Irving, Texas, United States 75063.
Crixeo Health Trust Score: 59/100 (POOR). This profile has not yet been claimed by the site owner.
Rocky Mountain Cancer Centers, LLP has participated in 2 clinical trials.
Therapeutic areas: Relapsed or Refractory Follicular Lymphoma, Relapsed or Refractory Diffuse Large B-Cell Lymphoma, Ovarian Cancer, Fallopian Tube Cancer.
Sponsors: Hoffmann-La Roche.
Trust Score: 59/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Rocky Mountain Cancer Centers, LLP has a Crixeo Trust Score of 59/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Rocky Mountain Cancer Centers, LLP has 2 clinical trials on record. Their work covers Relapsed or Refractory Follicular Lymphoma, Relapsed or Refractory Diffuse Large B-Cell Lymphoma, Ovarian Cancer, Fallopian Tube Cancer.
Rocky Mountain Cancer Centers, LLP has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.